 | | | | NEW DELHI (Reuters) -India is to fast-track emergency approvals for COVID-19 vaccines that have been authorised by Western countries and Japan, paving the way for possible imports of Pfizer, Johnson & Johnson, and Moderna shots. | | | | | | U.S. federal health agencies on Tuesday will call for an immediate pause in use of Johnson & Johnson's single-dose COVID-19 vaccine after six U.S. recipients developed a rare disorder involving blood clots, the New York Times reported, citing officials briefed on the decision. | | | | | | Japan's western region of Osaka reported a record number of infections of COVID-19 on Tuesday as a mutant strain of the virus fuelled a rebound in cases. | | | | | | Chancellor Angela Merkel on Tuesday said her decision to ask parliament for temporary powers that enables her government to enforce nationwide coronavirus lockdowns was necessary to curb a third wave of the pandemic in Germany. | | | | | | An outbreak of avian influenza has been detected on a chicken farm in South Africa's central province of Gauteng, the agricultural ministry said on Tuesday. | | | | | | International agencies including the World Health Organization urged countries on Tuesday to suspend the sale of live wild mammals in food markets, warning they may be the source of more than 70% of emerging infectious diseases in humans. | | | | | | (Reuters) -More than 136.71 million people have been reported to be infected by the novel coronavirus globally and 3,085,247 have died, a Reuters tally shows. | | | | | | LONDON (Reuters) -Britain has offered all over-50s a first dose of COVID-19 vaccine and launched the Moderna shot in England, the government said on Tuesday, putting it on track to give a shot to all adults by the end of July. | | | | | | British prime Minister Boris Johnson said COVID-19 infections and deaths would start to rise again as restrictions were eased despite the successful roll out of vaccinations to those aged above 50 and vulnerable groups. | | | | | | Novavax Inc has pushed back the timeline for hitting its production target of 150 million COVID-19 vaccine doses per month until the third quarter due to supply shortages including bags used to grow cells, a company spokeswoman told Reuters. | | | | | | China's locally developed COVID-19 vaccine candidate that uses messenger RNA (mRNA) technology could start late-stage clinical trial overseas as early as next month, official media said on Tuesday. | | | | | |
